Abstract | OBJECTIVE: The present randomized prospective study aimed to compare the effect of tibolone (T) with conventional low-dose estrogen- progestogen therapy (EPT) administered in a combined continuous regimen on the course of primary headaches in postmenopausal women requesting hormone therapy (HT) for climacteric complaints. DESIGN: Forty women presenting for clinical evaluation of headache (migraine without aura and episodic tension-type headache) were enrolled. The observational period lasted 7 months during which women kept a diary of the clinical characteristics of headache attacks and analgesic use. Climacteric symptoms and both anxiety and depression were also measured. After a 1-month run-in period, women received two different HT regimens: 1 mg 17beta-estradiol + 0.5 mg norethisterone acetate (EPT) or 2.5 mg T. Follow-up evaluations were planned after 3 and 6 months of treatment. RESULTS: Although T did not affect the number of days with migraine without aura, it significantly reduced the number of hours during which pain intensity prohibited daily activities (P < 0.001) and the number of analgesics (P < 0.001) after 3 months. Conventional low-dose EPT administered in a combined continuous regimen was confirmed to have a mild, but negative, effect on the course of migraine without aura by increasing the number of days with head pain (P < 0.001) and the number of analgesics (P < 0.001). Interestingly, both treatments were effective in the management of episodic tension-type headache, significantly reducing the number of days with head pain, severity, and analgesic consumption. CONCLUSIONS: In postmenopausal headache sufferers, analgesics are more effective in alleviating severe head pain when women are treated with T in comparison with low-dose EPT for climacteric complaints.
|
Authors | Rossella E Nappi, Grazia Sances, Arianna Sommacal, Silvia Detaddei, Fabio Facchinetti, Silvano Cristina, Franco Polatti, Giuseppe Nappi |
Journal | Menopause (New York, N.Y.)
(Menopause)
2006 Sep-Oct
Vol. 13
Issue 5
Pg. 818-25
ISSN: 1072-3714 [Print] United States |
PMID | 16894336
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Estrogen Receptor Modulators
- Norpregnenes
- tibolone
|
Topics |
- Analysis of Variance
- Estrogen Receptor Modulators
(administration & dosage, pharmacology)
- Estrogen Replacement Therapy
- Female
- Headache
(drug therapy)
- Humans
- Middle Aged
- Norpregnenes
(administration & dosage, pharmacology)
- Postmenopause
(drug effects)
- Prospective Studies
|